Applied Stem Cell, Inc. Strengthens Executive Leadership With Two Key Appointments
12/04/23, 2:53 PM
Location
milpitasIndustry
genetics
therapeutics
biotechnology
health care
Position
chief commercial officer
Applied StemCell Inc, a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief Operating Officer)
Company Info
Location
milpitas, california, united states
Additional Info
Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies.
Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases.